This subproject is one of many research subprojects utilizing theresources provided by a Center grant funded by NIH/NCRR. The subproject andinvestigator (PI) may have received primary funding from another NIH source,and thus could be represented in other CRISP entries. The institution listed isfor the Center, which is not necessarily the institution for the investigator.To evaluate the response rate, the duration of the response, time to progression and overall survival for patients with incurable head and neck cancer treated with depsipeptide.
Showing the most recent 10 out of 370 publications